参考文献/References:
[1]Bijlsma AY,Meskers CG,Westendorp RG,et al.Chronology of age-related disease definitions:osteoporosis and sarcopenia[J].Ageing Res Rev,2012,11(2):320-324. [2]马远征,王以朋,刘强,等.中国老年骨质疏松症诊疗指南(2018)[J].中国骨质疏松杂志,2018,24(12):1541-1567. [3]林金丁,郑毓嵩.经皮椎体成形术与经皮后凸成形术治疗椎体骨折疗效比较[J].福建医药杂志,2015,37(2):45-48. [4]Guo JB,Zhu Y,Chen BL,et al.Surgical versus non-surgical treatment for vertebral compression fracture with osteopenia:a systematic review and meta-analysis[J].PLoS One,2015(10):e0127145. [5]Kan SL,Yuan ZF,Chen LX,et al.Which is best for osteoporotic vertebral compression fractures:balloon kyphoplasty,percutaneous vertebroplasty or non-surgical treatment?A study protocol for a Bayesian network meta-analysis[J].BMJ Open,2017(7):e012937. [6]郭安丰.高黏度骨水泥应用于经皮椎体成形术术中的效果及对术后脊柱功能的影响分析[J].医学理论与实践,2020,33(3):418-419. [7]黄砖枝,陈志达,薛超,等.PVP与PKP治疗单节段骨质疏松性椎体骨折伴椎管狭窄的比较[J].中国矫形外科杂志,2019,27(10):890-894. [8]Hu KZ,Chen SC,Xu L.Comparison of percutaneous balloon dilation kyphoplasty and percutaneous vertebroplasty in treatment for thoracolumbar vertebral compression fractures[J].Eur Rev Med Pharmacol Sci,2018(22):96-102. [9]Yu HM,Li YZ,Yao XD,et al.Application of percutaneous vertebroplasty and percutaneous kyphoplasty in treating Kümmell’s patients with different stages and postural correction status[J].Expert Rev Med Devices,2020(17):357-364. [10]朱书涛,刘洋,张明辉,等.PKP术后患者再骨折危险因素分析[J].中国矫形外科杂志,2016,24(16):1445-1448. [11]林森,陈小强,周涛,等.骨质疏松性椎体压缩性骨折椎体成形术后再骨折的影响因素分析[J].中华临床医师杂志(电子版),2016,10(12):1670-1673.
相似文献/References:
[1]王 忻,赵 毅,朱 悦,等.甲状旁腺激素应用于大鼠脊髓损伤后防治骨质疏松的效果分析[J].医学信息,2018,31(02):54.[doi:10.3969/j.issn.1006-1959.2018.02.019]
WANG Xin,ZHAO Yi,ZHU Yue,et al.Effect of Parathyroid Hormone on Prevention and Treatment of
Osteoporosis after Spinal Cord Injury in Rats[J].Medical Information,2018,31(04):54.[doi:10.3969/j.issn.1006-1959.2018.02.019]
[2]吴玲,李玉兰.个性化心理护理干预应用于骨质疏松的临床效果观察[J].医学信息,2018,31(01):158.[doi:10.3969/j.issn.1006-1959.2018.01.062]
WU Ling,LI Yu-lan.The Clinical Effect of Personalized Psychological Nursing Intervention on Osteoporosis[J].Medical Information,2018,31(04):158.[doi:10.3969/j.issn.1006-1959.2018.01.062]
[3]杨可佳,孙春华,洪全明,等.经皮椎体成形术治疗骨质疏松性压缩性椎体骨折的疗效观察[J].医学信息,2018,31(17):98.[doi:10.3969/j.issn.1006-1959.2018.17.030]
YANG Ke-jia,SUN Chun-hua,HONG Quan-ming,et al.Therapeutic Effect of Percutaneous Vertebroplasty for treatment of Osteoporotic Vertebral Compression Fracture[J].Medical Information,2018,31(04):98.[doi:10.3969/j.issn.1006-1959.2018.17.030]
[4]蒋俊良.老年股骨转子间骨折的手术治疗方法[J].医学信息,2018,31(23):58.[doi:10.3969/j.issn.1006-1959.2018.23.017]
JIANG Jun-liang.Research Progress of Intertrochanteric Fractures of Femurin the Elderly[J].Medical Information,2018,31(04):58.[doi:10.3969/j.issn.1006-1959.2018.23.017]
[5]张 强,杨 帆,陈 康,等.椎体成形术中明胶海绵填塞治疗椎体前壁破损的
OVCFs的临床疗效观察[J].医学信息,2019,32(11):85.[doi:10.3969/j.issn.1006-1959.2019.11.023]
ZHANG Qiang,YANG Fan,CHEN Kang,et al.Clinical Observation of OVCFs in the Treatment of Anterior Wall Fracture of
Vertebral Body with Gelatin Sponge During Vertebroplasty[J].Medical Information,2019,32(04):85.[doi:10.3969/j.issn.1006-1959.2019.11.023]
[6]庞 渊,张 庆,阿伍提·艾克木,等.经皮椎体成形术治疗骨质疏松性椎体压缩性骨折的
疗效分析[J].医学信息,2019,32(11):116.[doi:10.3969/j.issn.1006-1959.2019.11.033]
PANG Yuan,ZHANG Qing,Awti Aikemu,et al.Therapeutic Effect of Percutaneous Vertebroplasty in the Treatment of
Osteoporotic Vertebral Compression Fractures[J].Medical Information,2019,32(04):116.[doi:10.3969/j.issn.1006-1959.2019.11.033]
[7]罗巧彦,凌止发,严宗逊,等.中老年女性骨代谢指标与骨质疏松的相关性研究[J].医学信息,2019,32(17):68.[doi:10.3969/j.issn.1006-1959.2019.17.021]
LUO Qiao-yan,LING Zhi-fa,YAN Zong-xun,et al.Correlation between Bone Metabolic Markers and Osteoporosis in Middle-aged and Elderly Women[J].Medical Information,2019,32(04):68.[doi:10.3969/j.issn.1006-1959.2019.17.021]
[8]熊义博,刘学员,邓泽熙,等.老年人骨质疏松与动脉硬化的关系[J].医学信息,2019,32(19):106.[doi:10.3969/j.issn.1006-1959.2019.19.033]
XIONG Yi-bo,LIU Xue-yuan,DENG Ze-xi,et al.Relationship Between Osteoporosis and Arteriosclerosis in the Elderly[J].Medical Information,2019,32(04):106.[doi:10.3969/j.issn.1006-1959.2019.19.033]
[9]常 双,殷晓明,殷兰芳,等.FRAX联合血清学指标评估老年T2DM患者骨质疏松风险的研究[J].医学信息,2022,35(16):76.[doi:10.3969/j.issn.1006-1959.2022.16.017]
CHANG Shuang,YIN Xiao-ming,YIN Lan-fang,et al.Evaluation of Osteoporosis Risk in Elderly Patients with T2DM by FRAX Combined with Serological Markers[J].Medical Information,2022,35(04):76.[doi:10.3969/j.issn.1006-1959.2022.16.017]
[10]贯福春.X线、MRI诊断原发性骨质疏松椎体压缩性骨折的价值[J].医学信息,2020,33(03):171.[doi:10.3969/j.issn.1006-1959.2020.03.057]
GUAN Fu-chun.The Value of X-ray and MRI in the Diagnosis of Primary Osteoporotic Compression Fracture of Vertebral Body[J].Medical Information,2020,33(04):171.[doi:10.3969/j.issn.1006-1959.2020.03.057]
[11]刘小花.经皮穿刺椎体成形术治疗老年性骨质疏松性
椎体压缩骨折的疗效分析[J].医学信息,2018,31(05):186.[doi:10.3969/j.issn.1006-1959.2018.05.070]
LIU Xiao-hua.The Effect of Percutaneous Vertebroplasty in the Treatment of Senile Osteoporotic Vertebral Compression Fracture[J].Medical Information,2018,31(04):186.[doi:10.3969/j.issn.1006-1959.2018.05.070]
[12]刘长志.经皮椎体成形术对骨质疏松性椎体压缩骨折患者VAS及ODI评分的影响[J].医学信息,2019,32(22):112.[doi:10.3969/j.issn.1006-1959.2019.22.036]
LIU Chang-zhi.Effect of Percutaneous Vertebroplasty on VAS and ODI Scores in Patients with Osteoporotic Vertebral Compression Fractures[J].Medical Information,2019,32(04):112.[doi:10.3969/j.issn.1006-1959.2019.22.036]
[13]谭兆惠.经皮椎体成形术与经皮椎体后凸成形术治疗重度骨质疏松性椎体压缩骨折的疗效[J].医学信息,2019,32(24):111.[doi:10.3969/j.issn.1006-1959.2019.24.038]
TAN Zhao-hui.Efficacy of Percutaneous Vertebroplasty and Percutaneous Kyphoplasty for Severe Osteoporotic Vertebral Compression Fractures[J].Medical Information,2019,32(04):111.[doi:10.3969/j.issn.1006-1959.2019.24.038]